Internal Medicine, Gastroenterology · Port Matilda, PA
NPI
1376572370
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
132 Abigail Ln
Port Matilda, PA, 16870
Phone (814) 272-5011
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
673 services
Medicare patients, 2024
413
Average age 71
Drug cost, 2024
$1.3M
682 prescriptions
Company payments, 2025
$25.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irphan E Gaslightwala was code 45385 (colonoscopy - lesion removal), 100 times for 99 patients. In total Irphan E Gaslightwala billed 673 services in 55 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Office | 100 | 99 | $198.55 | $20K |
| 99214 Office E&M - Established | Office | 73 | 60 | $84.87 | $6,195 |
| 45385 Colonoscopy - Lesion Removal | Facility | 56 | 54 | $189.91 | $11K |
| 45380 Lower GI Endoscopy - Other | Office | 42 | 42 | $98.38 | $4,132 |
| 43239 Upper GI Endoscopy | Facility | 40 | 38 | $51.54 | $2,062 |
| 99214 Office E&M - Established | Facility | 29 | 23 | $68.45 | $1,985 |
| 43239 Upper GI Endoscopy | Office | 25 | 23 | $53.11 | $1,328 |
| 43248 Upper GI Endoscopy | Facility | 21 | 20 | $103.60 | $2,176 |
| 45380 Lower GI Endoscopy - Other | Facility | 19 | 19 | $88.36 | $1,679 |
| 99222 Hospital E&M - Initial | Facility | 19 | 18 | $98.72 | $1,876 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 18 | 18 | $172.38 | $3,103 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 16 | $11.71 | $187 |
| 43248 Upper GI Endoscopy | Office | 15 | 15 | $104.30 | $1,565 |
| 43235 Upper GI Endoscopy | Facility | 14 | 13 | $88.40 | $1,238 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 13 | 13 | $165.57 | $2,152 |
By year: 2022 $60K for 548 services; 2023 $76K for 637 services; 2024 $76K for 673 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irphan E Gaslightwala prescribed most often to Medicare patients was Omeprazole, with 99 prescriptions and refills. In total Irphan E Gaslightwala wrote 682 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 99 | 223 | 36 | $1,062 |
| Mesalamine Generic | 63 | 112 | 13 | $29K |
| Stelara Ustekinumab | 41 | 52 | Under 11 | $1.1M |
| Ursodiol Generic | 30 | 87 | Under 11 | $7,372 |
| Linzess Linaclotide | 28 | 32 | Under 11 | $19K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 27 | 35 | Under 11 | $449 |
| Pantoprazole Sodium Generic | 26 | 67 | 14 | $595 |
| Ciprofloxacin Hcl Generic | 25 | 25 | 24 | $116 |
| Sucralfate Generic | 21 | 26 | 12 | $570 |
| Famotidine Generic | 21 | 43 | Under 11 | $281 |
| Metoclopramide Hcl Generic | 20 | 26 | 11 | $68.74 |
| Cholestyramine Cholestyramine (With Sugar) | 19 | 37 | Under 11 | $1,016 |
| Dicyclomine Hcl Generic | 16 | 38 | Under 11 | $605 |
| Motegrity Prucalopride Succinate | 16 | 32 | Under 11 | $16K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 16 | 16 | 16 | $84.42 |
Brand drugs: 168 claims; generic drugs: 514 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irphan E Gaslightwala $25.42 ($25.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Celltrion USA Inc. with $25.42.
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. 068270.KS | 1 | $25.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.